These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 4666480)
1. [Tumours and immunity. II. Special part. Tumour antigens. The immune response by neoplasms. Immunotherapy]. Ulvund MJ Nord Vet Med; 1972; 24(7):380-7. PubMed ID: 4666480 [No Abstract] [Full Text] [Related]
2. Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy. Pilch YH; Myers GH; Sparks FC; Golub SH Curr Probl Surg; 1975 Feb; ():1-61. PubMed ID: 1092529 [No Abstract] [Full Text] [Related]
3. The immunotherapy of cancer. Parker CW Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047 [No Abstract] [Full Text] [Related]
4. [Tumor immunology. General survey, diagnostic and prognostic aspects, immunotherapy]. Thunold S; Orjasaeter H; Engeset A Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1862-7. PubMed ID: 4129133 [No Abstract] [Full Text] [Related]
5. The immunology of cancer: avenues to immunotherapy. Woods AH Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414 [No Abstract] [Full Text] [Related]
6. Immunotherapy for cancer: an overview. Proctor JW; Lewis MG; Mansell PW Can J Surg; 1976 Jan; 19(1):12-9. PubMed ID: 1145 [TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of cancer immunity. Moore GE Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116 [No Abstract] [Full Text] [Related]
8. [The immunotherapeutic approaches to the management of leukemia and neoplasms]. Leu TP Zhonghua Yi Xue Za Zhi; 1974 May; 5():310-4. PubMed ID: 4211699 [No Abstract] [Full Text] [Related]
9. Regulatory T cells, tumour immunity and immunotherapy. Zou W Nat Rev Immunol; 2006 Apr; 6(4):295-307. PubMed ID: 16557261 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Zou W Nat Rev Cancer; 2005 Apr; 5(4):263-74. PubMed ID: 15776005 [TBL] [Abstract][Full Text] [Related]
11. Cellular and humoral immune responses of cancer patients to defined tumor antigens. Jäger D; Jäger E; Bert F; Knuth A Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025 [No Abstract] [Full Text] [Related]
13. Cancer immunotherapy: a treatment for the masses. Blattman JN; Greenberg PD Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469 [TBL] [Abstract][Full Text] [Related]
14. Malignant tumours and immunity. Schuler D Ther Hung; 1972; 20(3):83-90. PubMed ID: 4121150 [No Abstract] [Full Text] [Related]
15. Cancer immunotherapy. Falk RE Can Med Assoc J; 1979 Feb; 120(3):255, 258. PubMed ID: 311678 [No Abstract] [Full Text] [Related]
16. [Immune therapy in cancer should be included in oncology education]. Osterberg S Lakartidningen; 1974 Oct; 71(43):4178-80. PubMed ID: 4425158 [No Abstract] [Full Text] [Related]
17. [Immunotherapy of neoplasms]. Trepel F Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109 [No Abstract] [Full Text] [Related]
18. Tumour immunotherapy: the adjuvant treatment of the 21st century? Bremers AJ; Kuppen PJ; Parmiani G Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365 [TBL] [Abstract][Full Text] [Related]
19. Current condition and prognosis of tumor immunotherapy: a second opinion. Mastrangelo MJ; Berd D; Maguire HC Cancer Treat Rep; 1984 Jan; 68(1):207-19. PubMed ID: 6362864 [No Abstract] [Full Text] [Related]
20. Immunity to cancer II. Proceedings of the Second Conference on Immunity to Cancer. Williamsburg, Virginia, November 9-11, 1987. Prog Clin Biol Res; 1989; 288():1-520. PubMed ID: 2717637 [No Abstract] [Full Text] [Related] [Next] [New Search]